Published in Eur Urol on December 13, 2008
Management of pelvic lymphoceles following robot-assisted laparoscopic radical prostatectomy. Urol Ann (2012) 1.20
Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy. Cancer (2011) 1.16
Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures. J Endourol (2011) 0.89
Extended lymph node dissection in robot-assisted radical prostatectomy: lymph node yield and distribution of metastases. Asian J Androl (2014) 0.84
Robotic-assisted laparoscopic prostatectomy. Br J Cancer (2009) 0.83
Robotic-assisted laparoscopic prostatectomy for high-risk prostate cancer: technical considerations and review of the literature. ISRN Urol (2011) 0.79
Editorial comment on: Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur Urol (2008) 0.78
Clinical value of extended pelvic lymph node dissection in patients subjected to radical prostatectomy. Wideochir Inne Tech Maloinwazyjne (2014) 0.77
Capsular incision in normal prostatic tissue during robot-assisted radical prostatectomy: a new concept or a waste of time? World J Urol (2013) 0.77
Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy. Investig Clin Urol (2016) 0.75
Extended lymph node dissection in robotic radical prostatectomy: Current status. Indian J Urol (2016) 0.75
Robot-Assisted Extended Pelvic Lymph Nodes Dissection for Prostate Cancer: Personal Surgical Technique and Outcomes. Int Braz J Urol (2016) 0.75
Robotic prostatectomy: an update on functional and oncologic outcomes. Ecancermedicalscience (2013) 0.75
Editorial comment on: Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur Urol (2008) 0.75
Prostate cancer: risk versus benefit of lymph node dissection during prostatectomy. Nat Rev Urol (2013) 0.75
Clinical impact of prostate biopsy undergrading in an academic and community setting. World J Urol (2016) 0.75
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications. Eur Urol (2009) 2.76
Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res (2002) 2.34
Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol (2005) 2.03
Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol (2009) 1.87
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. Eur Urol (2013) 1.69
Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate. Eur Urol (2008) 1.62
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol (2008) 1.60
Life-threatening complication after right renal extracorporeal shock wave lithotripsy: large hepatic haematoma requiring embolisation of the right hepatic artery. Eur Urol (2007) 1.57
In vivo identification of uric acid stones with dual-energy CT: diagnostic performance evaluation in patients. Abdom Imaging (2009) 1.56
Intermediate-term results of retroperitoneoscopy-assisted cryotherapy for small renal tumours using multiple ultrathin cryoprobes. Eur Urol (2006) 1.53
Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol (2007) 1.52
Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol (2010) 1.52
High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol (2005) 1.51
Laparoscopy in German urology: changing acceptance among urologists. Eur Urol (2008) 1.51
Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol (2006) 1.50
The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis. Eur Urol (2013) 1.47
Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation. Urol Res (2008) 1.45
Lateral temperature spread of monopolar, bipolar and ultrasonic instruments for robot-assisted laparoscopic surgery. BJU Int (2014) 1.44
A new high frequency electrostimulation device to treat chronic prostatitis. J Urol (2003) 1.41
Retroperitoneoscopic living donor nephrectomy: a retrospective comparison to the open approach. Transplantation (2004) 1.39
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res (2011) 1.38
Is kidney surgery going to be minimally invasive in all cases? Eur Urol (2007) 1.38
Long-term experience with surgical and conservative treatment of penile fracture. J Urol (2004) 1.37
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer (2002) 1.28
Loss of PBRM1 expression is associated with renal cell carcinoma progression. Int J Cancer (2012) 1.27
Activities of MAP-kinase pathways in normal uroepithelial cells and urothelial carcinoma cell lines. Exp Cell Res (2003) 1.21
Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer (2010) 1.21
FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer. Am J Pathol (2011) 1.20
Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol (2004) 1.18
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer (2006) 1.15
Laparoscopic radical prostatectomy--the experience of the German Laparoscopic Working Group. Eur Urol (2005) 1.14
Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol (2005) 1.12
Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am J Obstet Gynecol (2005) 1.11
Engineering functional bladder tissues. J Tissue Eng Regen Med (2012) 1.10
Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int J Cancer (2003) 1.10
Phosphorylation of the Arp2/3 complex is necessary to nucleate actin filaments. J Cell Biol (2008) 1.09
Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol (2009) 1.07
Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res (2009) 1.06
An unusual splice defect in the mitofusin 2 gene (MFN2) is associated with degenerative axonopathy in Tyrolean Grey cattle. PLoS One (2011) 1.05
VHL gene mutations and their effects on hypoxia inducible factor HIFα: identification of potential driver and passenger mutations. Cancer Res (2011) 1.05
Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates. Prostate (2011) 1.03
Chyloretroperitoneum with secondary chylothorax after retroperitoneoscopic donor nephrectomy. Urology (2005) 1.01
TGF-b2 induction regulates invasiveness of Theileria-transformed leukocytes and disease susceptibility. PLoS Pathog (2010) 1.00
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy. Int J Cancer (2009) 1.00
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. Int J Cancer (2008) 0.99
Multiple mechanisms downregulate CDKN1C in human bladder cancer. Int J Cancer (2005) 0.98
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer. PLoS One (2011) 0.97
Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers. Invest Radiol (2013) 0.96
Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol (2004) 0.95
Delayed infection of a pelvic lymphocele following robotic radical prostatectomy and pelvic lymphadenectomy: two cases. Urol Int (2009) 0.93
c-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes. Oncogene (2005) 0.93
Prospective evaluation of irrigation fluid absorption during pure transurethral bipolar plasma vaporisation of the prostate using expired-breath ethanol measurements. BJU Int (2013) 0.92
Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol (2006) 0.91
Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer. Int J Cancer (2008) 0.91
The association between component malalignment and post-operative pain following navigation-assisted total knee arthroplasty: results of a cohort/nested case-control study. Knee Surg Sports Traumatol Arthrosc (2009) 0.91
Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way? J Urol (2011) 0.91
Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clin Cancer Res (2009) 0.90
An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system. Am J Clin Pathol (2006) 0.90
Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines. J Cell Physiol (2005) 0.89
Current laparoscopic practice patterns in urology: results of a survey among urologists in Germany and Switzerland. Eur Urol (2002) 0.89
Multidisciplinary care in patients with prostate cancer: room for improvement. Support Care Cancer (2013) 0.88
Relevance of periostin splice variants in renal cell carcinoma. Am J Pathol (2011) 0.88
Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer. Eur J Nucl Med Mol Imaging (2012) 0.88
The Value of Prognostic Grouping of Prostatic Carcinomas for Urologists and Pathologists. Urol Int (2015) 0.87
Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res (2009) 0.87
Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression. Virchows Arch (2013) 0.87
NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma. Acta Neuropathol Commun (2014) 0.86
High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. Eur J Cancer (2008) 0.86
Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma. Neoplasia (2012) 0.86
Thermal spread of vessel-sealing devices evaluated in a clinically relevant in vitro model. Urol Int (2011) 0.86
Retroperitoneoscopy-assisted cryoablation of renal tumors using multiple 1.5 mm ultrathin cryoprobes: a preliminary report. Eur Urol (2005) 0.86
Retroperitoneoscopic donor nephrectomy: donor outcome and complication rate in comparison with three different techniques. World J Urol (2006) 0.85
Artificial prostate-specific antigen persistence after radical prostatectomy. J Clin Oncol (2011) 0.85
The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study. Lasers Med Sci (2015) 0.85
Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status. Urology (2004) 0.85
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis. Cancer Epidemiol Biomarkers Prev (2009) 0.85
c-Src is a PDZ interaction partner and substrate of the E3 ubiquitin ligase Ligand-of-Numb protein X1. FEBS Lett (2007) 0.84
How painful is donor nephrectomy? Retrospective analysis of early pain and pain management in open versus laparoscopic versus retroperitoneoscopic nephrectomy. Transplantation (2006) 0.84
The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro. Am J Pathol (2011) 0.84
Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology. Eur Urol (2004) 0.84
Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland. Swiss Med Wkly (2010) 0.83
Retroperitoneoscopic management of caliceal diverticular calculi. Urology (2005) 0.83
Actin-mediated plasma membrane plasticity of the intracellular parasite Theileria annulata. Cell Microbiol (2012) 0.83
Multisystem neuroprosthetic training improves bladder function after severe spinal cord injury. J Urol (2012) 0.83
Regulation of c-Src by binding to the PDZ domain of AF-6. EMBO J (2007) 0.83